Pharmaceutical

Lupin receives European Commission approval for biosimi...

Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU throu...

Roche receives FDA acceptance for giredestrant combo NDA

The submission targets adult patients with oestrogen receptor (ER)-positive, hum...

Updated Balance Requirements in the Pharmaceutical Indu...

Laboratory balance requirements across global pharmacopeias have been significa...

Dr Reddy’s submits Abatacept Biosimilar BLA to USFDA fo...

351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid ...

Morepen Laboratories secures ₹825 Cr CDMO mandate from ...

Multi-year contract to commence supplies within 4–5 months, execution planned t...

Boehringer Ingelheim and NIPER sign MoU on pharmaceutic...

The MoU with the National Institute of Pharmaceutical Education and Research (NI...

Syngene and VivaMed collaborate on therapeutic programmes

This partnership aims to broaden VivaMed’s validation infrastructure for AI-driv...

Global Pain Therapeutics market shows scope for non-opi...

Report highlights voltage-gated sodium channel inhibitors, pipeline trends and ...

MSD and Mayo Clinic team up to advance AI in drug devel...

The collaboration will combine Mayo Clinic’s Platform architecture and clinical-...

Novartis enters licensing agreement with UNP for peptid...

The partnership combines UNP’s AI-driven macrocycle platform with the worldwide ...

Cadila Pharmaceuticals marks 100th birth anniversary of...

Company commemorates centenary of founder and recalls his role in building Indi...

Queensland delegation concludes BioAsia 2026 mission to...

TIQ and Austrade engage with Indian biotech, clinical trials and MedTech stakeh...

When companies break bad: Directors’ liability under Dr...

Vineet Unnikrishnan and Sonu Bhasi examine the scope of directors’ liability an...

Zydus Lifesciences launches Anyra, biosimilar of Aflibe...

Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic...

Dr Reddy’s Laboratories acquires Progynova and Cyclo-Pr...

Acquisition strengthens gynaecology portfolio and marks entry into hormone repl...

J&J’s Rybrevant Faspro gains FDA approval for new dosin...

This combination, used alongside Lazcluze (lazertinib), is indicated as a first-...